Ted Halmos
Boehringer Ingelheim (Canada)(CA)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, Hepatitis C virus research, Monoclonal and Polyclonal Antibodies Research, HIV Research and Treatment, Chemical Synthesis and Analysis
Most-Cited Works
- → Structure−Activity Study on a Novel Series of Macrocyclic Inhibitors of the Hepatitis C Virus NS3 Protease Leading to the Discovery of BILN 2061(2004)186 cited
- → Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1(2014)176 cited
- → Peptide-based inhibitors of the hepatitis C virus serine protease(1998)162 cited
- → A Systematic Approach to the Optimization of Substrate-Based Inhibitors of the Hepatitis C Virus NS3 Protease: Discovery of Potent and Specific Tripeptide Inhibitors(2004)122 cited
- → Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitors(2000)108 cited
- → Synthesis of BILN 2061, an HCV NS3 Protease Inhibitor with Proven Antiviral Effect in Humans(2004)103 cited
- → An NS3 Serine Protease Inhibitor Abrogates Replication of Subgenomic Hepatitis C Virus RNA(2003)91 cited
- → Discovery of a Potent and Selective Noncovalent Linear Inhibitor of the Hepatitis C Virus NS3 Protease (BI 201335)(2010)89 cited
- → Peptidomimetic Inhibitors of the Human Cytomegalovirus Protease(1997)85 cited
- → Studies on the C-terminal of hexapeptide inhibitors of the hepatitis C virus serine protease(1998)84 cited